Assessing and improving the reliability of meta-analyses of hazard ratios derived from published time-to-event data by Jayne Tierney et al.
ORAL PRESENTATION Open Access
Assessing and improving the reliability of
meta-analyses of hazard ratios derived
from published time-to-event data
Jayne Tierney1, David Fisher1*, Sarah Burdett1, Lesley Stewart2, Mahesh Parmar1
From 2nd Clinical Trials Methodology Conference: Methodology Matters
Edinburgh, UK. 18-19 November 2013
Background
Trial design and conduct is informed by systematic
reviews and meta-analyses (MAs). For time-to-event
outcomes, they are typically based on hazard ratios
(HRs). Ideally, these are calculated from individual
patient data (IPD). Alternatively, they can be extracted
from published aggregate data (AD) or estimated from
other statistics or from Kaplan-Meier (KM) curves. As
reporting and the reliability of each estimation method
is likely variable, we investigate how HRs from AD and
IPD compare.
Methods
We used 18 of our published IPD systematic reviews and
MAs. For our primary outcome of overall survival, we
extracted or estimated logHRs and standard errors (SEs)
from eligible trials wherever possible. We compared HRs
from AD and IPD at the trial and meta-analysis level,
using Bland-Altman methods to assess agreement.
Results
Of 245 unique trials eligible for the meta-analyses, HRs
were available from IPD for 199 (81%), and from AD for
155 (63%) including 75 (48%) based on KM curves. Trial
logHRs from AD were biased towards benefit compared
to IPD (5% on HR scale, p=0.009), and SEs were inflated
(+0.23 SDs, p<0.001). Bias was not influenced by estima-
tion method (p=0.84). Similar bias was seen in MA
logHRs from AD (3.5% on HR scale, p=0.031), and
again inflated SEs (+0.87 SDs, p<0.001). The level of
bias varied by meta-analysis.
Conclusions
Although MAs of AD-derived HRs can be biased, their
use is widespread and needed when the IPD approach is
infeasible. We will present results on causes of these
biases and guidance on overcoming them.
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